The Department of Justice (DOJ) has declined to prosecute a New Jersey health business for fraud, kickbacks and bribery, while indicting the chief executive on multiple counts.
Adrianne Appel writes regulatory news, policy, and trends for Compliance Week. She previously reported about policy developments for Bloomberg Law and Bloomberg Government.
At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.
